Varicella-Zoster Virus DNA in Blood after Administration of Herpes Zoster Vaccine

10Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We studied the relationship between varicella-zoster virus (VZV) DNAemia and development of VZV-specific immunity after administration of live-attenuated zoster vaccine. VZV-DNAemia, detected by polymerase chain reaction (PCR), and VZV-specific effector (Teff) and memory (Tmem) T cells, was measured in 67 vaccinees. PCR was positive in 56% (9 direct, 28 nested) on day 1 and in 16% (1 direct, 10 nested) on day 14. Teff progressively increased in direct-PCR-positive vaccinees up to day 30, but Tmem did not. Conversely, Tmem, but not Teff, increased in direct-PCR-negative vaccinees on day 7. The kinetics of these immune responses and VZV DNAemia suggested that direct-PCR sample positive represented viremia.

Cite

CITATION STYLE

APA

Levin, M. J., Cai, G. Y., Lee, K. S., Rouphael, N. G., Mehta, A. K., Canniff, J., … Weinberg, A. (2018). Varicella-Zoster Virus DNA in Blood after Administration of Herpes Zoster Vaccine. Journal of Infectious Diseases, 217(7), 1055–1059. https://doi.org/10.1093/infdis/jix653

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free